UnitedHealth Group’s (UNH) “Buy” Rating Reaffirmed at Truist Financial

Truist Financial reissued their buy rating on shares of UnitedHealth Group (NYSE:UNH) in a report published on Wednesday morning, Benzinga reports. Truist Financial currently has a $600.00 price objective on the healthcare conglomerate’s stock.

Several other research firms have also recently commented on UNH. TD Cowen lowered their price target on UnitedHealth Group from $607.00 to $546.00 and set a buy rating for the company in a report on Wednesday, April 10th. Erste Group Bank restated a hold rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Royal Bank of Canada reaffirmed an outperform rating and issued a $596.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 29th. Oppenheimer reissued an outperform rating and set a $610.00 price target on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Finally, Cantor Fitzgerald reaffirmed an overweight rating and issued a $591.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Three research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of Moderate Buy and an average target price of $569.68.

UnitedHealth Group Trading Up 2.2 %

Shares of UNH stock opened at $478.99 on Wednesday. UnitedHealth Group has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The stock has a market cap of $441.60 billion, a P/E ratio of 29.28, a P/E/G ratio of 1.28 and a beta of 0.54. The business has a fifty day simple moving average of $489.51 and a 200-day simple moving average of $515.38. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the previous year, the company posted $6.26 EPS. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. On average, analysts forecast that UnitedHealth Group will post 27.75 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.57%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is 45.97%.

Insider Activity

In related news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of UNH. Robbins Farley bought a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $25,000. Richelieu Gestion SA bought a new position in UnitedHealth Group during the 4th quarter worth about $26,000. CGC Financial Services LLC increased its holdings in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares in the last quarter. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $31,000. Finally, NewSquare Capital LLC boosted its stake in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 51 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.